G. Iliceto

发表

Proton magnetic resonance spectroscopy in Parkinson's disease and progressive supranuclear palsy.

F Federico, P. Lamberti, I. Simone, 1997, Journal of neurology, neurosurgery, and psychiatry.

Effects of levodopa and COMT inhibitors on plasma homocysteine in Parkinson's disease patients

P. Livrea, P. Lamberti, S. Zoccolella, 2005, Movement disorders : official journal of the Movement Disorder Society.

Gender effect on non-motor symptoms in Parkinson's disease: are men more at risk?

R. Marconi, P. Barone, A. Quattrone, 2017, Parkinsonism & related disorders.

Head trauma and Parkinson’s disease: results from an Italian case-control study

R. Marconi, P. Barone, A. Quattrone, 2017, Neurological Sciences.

A case of concomitant amyotrophic lateral sclerosis and HIV infection

P. Lamberti, S. Zoccolella, S. Carbonara, 2002, European journal of neurology.

Predictors of survival in a series of clinically diagnosed progressive supranuclear palsy patients.

G. Logroscino, V. Cardinali, P. Lamberti, 2013, Parkinsonism & related disorders.

Diaphragmatic flutter, the moving umbilicus syndrome, and “belly dancer's” dyskinesia

B. Day, P. Thompson, C. Marsden, 1990, Movement disorders : official journal of the Movement Disorder Society.

Efficacy and tolerability of dopamine agonists in a parkinsonian population

G. Iliceto, A. Moramarco, A. Fraddosio, 2001, Neurological Sciences.

Natural history and clinical features of progressive supranuclear palsy: a clinical study

G. Iliceto, A. Fraddosio, C. Dell'aquila, 2003, Neurological Sciences.

Effect of L‐dopa on oculogyric crises in a case of dopa‐responsive dystonia

P. Lamberti, M. de Mari, G. Iliceto, 1993, Movement disorders : official journal of the Movement Disorder Society.

Plasma homocysteine levels in Parkinson's disease: role of antiparkinsonian medications.

P. Livrea, P. Lamberti, S. Zoccolella, 2005, Parkinsonism & related disorders.

Subclinical upper motor neuron involvement at the diagnosis may predict disease progression in a cohort of lower motor neuron syndromes from Southern Italy

I. Simone, S. Zoccolella, G. Iliceto, 2021, Journal of the Neurological Sciences.

Inclusion of motor evoked abnormalities in amyotrophic lateral sclerosis: a diagnostic algorithm to early classify lower motor neuron phenotypes

I. Simone, S. Zoccolella, A. Scarafino, 2020, Amyotrophic lateral sclerosis & frontotemporal degeneration.

Motoneuron disease after electric injury: a case report

P. Lamberti, S. Zoccolella, D. Mezzapesa, 2008, Neurological Sciences.

ALS-plus: 5 cases of concomitant amyotrophic lateral sclerosis and parkinsonism

S. Zoccolella, F. Maggio, G. Iliceto, 2002, Neurological Sciences.

ATP13A2 missense mutations in juvenile parkinsonism and young onset Parkinson disease

R. Marconi, M. Horstink, B. Oostra, 2007, Neurology.

Rest tremor in Parkinson's disease: Body distribution and time of appearance

Giovanni Defazio, Roberta Pellicciari, Daniele Liuzzi, 2017, Journal of the Neurological Sciences.

Topographic EEG mapping of 3/s spike-and-wave complexes during absence seizures

R. Ferri, G. Iliceto, V. Carlucci, 1995, The Italian Journal of Neurological Sciences.

Freezing gait in Parkinson's disease.

S. Armenise, P. Lamberti, P Lamberti, 1997, European neurology.

Subclinical visual involvement in multiple sclerosis: a study by MRI, VEPs, frequency-doubling perimetry, standard perimetry, and contrast sensitivity.

M. Trojano, D. Sisto, M. Vetrugno, 2005, Investigative ophthalmology & visual science.

Proton magnetic resonance spectroscopy in parkinson's disease and atypical parkinsonian disorders

Francesco Federico, Paolo Lamberti, P. Lamberti, 1997 .

Action tremor in Parkinson's disease: frequency and relationship to motor and non‐motor signs

M. Guido, G. Defazio, P. Livrea, 2015, European journal of neurology.

Motor-evoked potentials in amyotrophic lateral sclerosis: potential implications in detecting subclinical UMN involvement in lower motor neuron phenotype

I. Simone, S. Zoccolella, A. Scarafino, 2020, Journal of Neurology.

Clinical phenotype and risk of levodopa-induced dyskinesia in Parkinson’s disease

R. Marconi, P. Barone, A. Quattrone, 2016, Journal of Neurology.

Plasma homocysteine levels in L-dopa-treated Parkinson's disease patients with cognitive dysfunctions

G. Defazio, P. Livrea, P. Lamberti, 2005, Clinical chemistry and laboratory medicine.

Smoking in Patients with Parkinson's Disease: preliminary striatal DaT‐SPECT findings

G. Defazio, P. Livrea, G. Rubini, 2016, Acta neurologica Scandinavica.

Hyperhomocysteinemia in l‐dopa treated Parkinson's disease patients: effect of cobalamin and folate administration

P. Livrea, P. Lamberti, S. Zoccolella, 2005, European journal of neurology.

Management of L-Dopa related hyperhomocysteinemia: catechol-O-methyltransferase (COMT) inhibitors or B vitamins? Results from a review

P. Livrea, P. Lamberti, S. Zoccolella, 2007, Clinical chemistry and laboratory medicine.

Hyperhomocysteinemia in L-dopa treated patients with Parkinson's disease: potential implications in cognitive dysfunction and dementia?

G. Logroscino, P. Lamberti, S. Zoccolella, 2010, Current medicinal chemistry.

Smoking and age-at-onset of both motor and non-motor symptoms in Parkinson's disease.

G. Defazio, A. Gigante, G. Iliceto, 2017, Parkinsonism & related disorders.

Chronic coffee consumption and striatal DAT-SPECT findings in Parkinson’s disease

G. Defazio, G. Rubini, A. Gigante, 2018, Neurological Sciences.

Predictors of survival in a series of clinically diagnosed progressive supranuclear palsy patients.

G. Logroscino, V. Cardinali, P. Lamberti, 2013, Parkinsonism & Related Disorders.